An exclusively developed patented TCM product of the company, included in the National Medical Insurance Category B Catalog, and also incorporated into the Expert Consensus on Chinese Patent Medicines for the Prevention and Treatment of Pan-Vascular Diseases and Their Target Organ Damage and the Guidelines for Rational Use of Blood-Stasis-Removing Chinese Patent Medicines. With a scientific formulation, it possesses the effects of promoting blood circulation to remove blood stasis and replenishing qi to unblock meridians, suitable for the recovery period of apoplectic disease with qi deficiency and blood stasis syndrome. Currently, it is widely used in over 380 Grade A and Grade B hospitals nationwide, and has been approved for marketing in multiple 'Belt and Road' countries and regions. Its efficacy has been highly recognized by the medical community and patients.